In this episode, we talk to Dr. Margie Morgan and Dr. Deisy Contreras from Cedars-Sinai Medical Center, a non-profit hospital and medical research institution that serves the Los Angeles community and surrounding areas.
With pioneering medical research achievements, healthcare-defining education programs, and wide-ranging community benefit activities, Cedars-Sinai is setting new standards for quality and innovation in patient care.
In this episode, we talk to Dr. Margie Morgan and Dr. Deisy Contreras from Cedars-Sinai Medical Center, a non-profit hospital and medical research institution that serves the Los Angeles community and surrounding areas.
With pioneering medical research achievements, healthcare-defining education programs, and wide-ranging community benefit activities, Cedars-Sinai is setting new standards for quality and innovation in patient care.
NB: reference to MALDI-TOF means Bruker's MALDI Biotyper and as below:
In this podcast, Bernd Merkl, Business Unit Director Mycobacteria / TB at Bruker Microbiology and Infection Diagnostics, is joined by Professor Stefan Niemann and Dr. Inna Friesen from the National Reference Center for Mycobacteria in Germany, to discuss the evolving Tuberculosis landscape, the scale of the issue and new testing methods that are helping limit the impact on public health.